How can markets better value nature and price the benefits of conservation?

Thursday, May 16, 2024, 2:00 – 3:30 p.m. EDT
The Brookings Institution, Falk Auditorium, 1775 Massachusetts Ave. NW. Washington, D.C.

The devastating effects of environmental degradation have intensified in recent decades, with a rapid decrease in biodiversity, the continuing destruction of many of our most valuable rainforests and natural habitats, and a steep increase in the number of endangered species. Many of these problems are expected to become worse with climate change, and they have substantially negative effects on our quality of life, our ability to provide enough food and water for our populations, and on public health. One driving cause of this environmental destruction is markets currently only attach value to natural assets when they are used (e.g., a rainforest’s value comes from cutting down and selling the trees)—conservation has no inherent value in the current system.

On May 16, the Brookings Center on Regulation and Markets (CRM) will host an event to explore how the intrinsic value of nature could be better accounted for by economists and priced by markets. A panel of experts will discuss innovate new ideas in this space like the concept of a natural asset company and other potential ways to use markets for the conservation of natural resources. The experts on the panel include Douglas Eger (Intrinsic Exchange Group), Kelly Shue (Yale School of Management), Pushpam Kumar (United Nations Environment Programme), Greta Talbot-Jones (Aviva Investors), and Rich Stockdale (Oxygen Conservation). The panel will be moderated by CRM Director Sanjay Patnaik.

This event is a part of the CRM series on Reimagining Modern-day Markets and Regulations. Viewers can join the conversation and ask questions of the speakers by emailing events@brookings.edu or on X/Twitter at @BrookingsEcon using the hashtag #ValuingNature.


Registration is required to attend an event in person and guests at Brookings are required to attest to their state of health before attending. Visitors may not enter the building if they are feeling ill for any reason, have any symptoms commonly associated with COVID-19, or have tested positive for COVID-19 at any time in the preceding 5 days or longer in accordance with current CDC guidance, or have been advised by their healthcare professional or otherwise to not enter any space where some persons may not be vaccinated.

Register to attend in person:

The Brookings Institution, 1775 Massachusetts Ave NW, Washington, DC 20036

Select event topics you're interested in  | View all Brookings Events